Levi & Korsinsky, LLP notifies investors in MacroGenics, Inc. (“MacroGenics” or the “Company”) (NASDAQ: MGNX) of a class action securities lawsuit.
https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of MacroGenics investors who were adversely affected by alleged securities fraud between March 7, 2024 and May 9, 2024. Follow the link below to get more information and be contacted by a member of our team:
MGNXinvestors may also contact Joseph E. Levi, Esq. via email atjlevi@levikorsinsky.comor by telephone at (212) 363-7500.
CASE DETAILS: During the class period, Defendants made material misrepresentations about the safety data from its TAMARACK Phase 2 study of vobramitamab duocarmazine. On May 9, 2024, the investing public learned that the drug was significantly more dangerous than defendants had previously represented. Following this news, MGNX’s stock declined 77.4% due to a drop of $11.36/share.
WHAT’S NEXT? If you suffered a loss in MacroGenics during the relevant time frame, you have until September 24, 2024to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.
WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.
CONTACT:Levi & Korsinsky, LLP Joseph E. Levi, Esq.Ed Korsinsky, Esq.33 Whitehall Street, 17th FloorNew York, NY 10004jlevi@levikorsinsky.comTel: (212) 363-7500Fax: (212) 363-7171www.zlk.com
https://c212.net/c/img/favicon.png?sn=NY11020&sd=2024-09-20
View original content to download multimedia:https://www.prnewswire.com/news-releases/contact-levi–korsinsky-by-september-24-2024-deadline-to-join-class-action-against-macrogenics-incmgnx-302253414.html
SOURCE Levi & Korsinsky, LLP
https://rt.newswire.ca/rt.gif?NewsItemId=NY11020&Transmission_Id=202409200555PR_NEWS_USPR_____NY11020&DateId=20240920
COMTEX_457956806/1005/2024-09-20T05:55:26